Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06302868 · ClinicalTrials.gov registry record · NA
Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias
A NA study of Arachnophobia and Cynophobia, sponsored by University of South Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06302868 is a NA study of Arachnophobia and Cynophobia that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06302868, a NA study of Arachnophobia and Cynophobia, is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.
Conditions Studied
Interventions
- BEHAVIORAL Telemedicine Exposure Therapy Using Photos and Videos
- BEHAVIORAL Telemedicine-Based Virtual Reality Exposure Therapy
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06302868
The ClinicalTrials.gov registry entry for NCT06302868 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Arachnophobia appearing as the primary indexed condition, and to 2 interventions - of which Telemedicine Exposure Therapy Using Photos and Videos is the first listed.
NCT06302868 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06302868 about?
NCT06302868 is a clinical study titled "Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias". The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or...
What is the current status of trial NCT06302868?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-10-03. Estimated completion is 2024-08-01.
What conditions does trial NCT06302868 study?
This clinical trial studies the following conditions: Arachnophobia, Cynophobia, Ophidiophobia.
What interventions are being tested in trial NCT06302868?
The interventions under investigation include: Telemedicine Exposure Therapy Using Photos and Videos (BEHAVIORAL), Telemedicine-Based Virtual Reality Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06302868?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06302868 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arachnophobia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.